202.49

5.08% 9.78

Inspire Medical Systems Inc (INSP)

Overview News Price History Option Chain Financials Why INSP Down? Discussions Forecast

Inspire Medical Systems Inc stock is traded at $202.49, with a volume of 1.04M. It is up +5.08% in the last 24 hours and down -5.78% over the past month. Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Previous Close:

$192.71

Open:

$198.83

24h Volume:

1.04M

Relative Volume:

1.78

Market Cap:

$5.89B

Revenue:

$705.71M

Net Income/Loss:

$6.01M

P/E Ratio:

-140.62

EPS:

-1.44

Net Cash Flow:

$-9.42M

1W Performance:

+1.71%

1M Performance:

-5.78%

6M Performance:

-18.91%

1Y Performance:

+19.33%

1-Day Range:

$186.38

$204.90

1-Week Range:

$186.38

$204.90

52-Week Range:

$123.00

$257.40

Inspire Medical Systems Inc Stock (INSP) Company Profile

Name

Inspire Medical Systems Inc

Sector

Healthcare (1181)

Industry

Medical Devices (155)

Phone

763-957-5037

Address

5500 WAYZATA BLVD, GOLDEN VALLEY

Employee

1,011

Twitter

@inspiresleep

Next Earnings Date

2024-11-04

Latest SEC Filings

INSP's Discussions on Twitter

Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-19-24	Initiated	RBC Capital Mkts	Outperform
Mar-19-24	Initiated	Morgan Stanley	Overweight
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight
Jan-19-24	Initiated	Jefferies	Buy
Jan-02-24	Downgrade	Stifel	Buy → Hold
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Apr-14-23	Initiated	Mizuho	Buy
Mar-29-23	Initiated	UBS	Buy
Dec-13-22	Upgrade	Goldman	Neutral → Buy
Dec-13-22	Initiated	KeyBanc Capital Markets	Overweight
Apr-13-22	Initiated	Truist	Buy
Apr-06-22	Initiated	Wolfe Research	Peer Perform
Mar-02-22	Resumed	BofA Securities	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Nov-03-20	Upgrade	BofA Securities	Neutral → Buy
Nov-03-20	Upgrade	Oppenheimer	Underperform → Perform
Sep-22-20	Initiated	JP Morgan	Overweight
Sep-02-20	Initiated	Robert W. Baird	Outperform
Aug-06-20	Downgrade	BofA Securities	Buy → Neutral
Jul-15-20	Initiated	Goldman	Buy
Jun-18-20	Reiterated	Piper Sandler	Overweight
May-18-20	Initiated	Lake Street	Buy
Apr-28-20	Upgrade	BofA/Merrill	Neutral → Buy
Apr-09-20	Initiated	Piper Sandler	Overweight
Jan-28-20	Initiated	Oppenheimer	Underperform
Jan-27-20	Initiated	Oppenheimer	Underperform
Nov-06-19	Upgrade	Berenberg	Sell → Hold
Feb-05-19	Initiated	Dougherty & Company	Buy
Nov-28-18	Initiated	Berenberg	Sell
Oct-29-18	Initiated	Leerink Partners	Outperform
May-29-18	Initiated	Guggenheim	Buy
May-29-18	Initiated	Stifel	Buy
May-29-18	Initiated	Wells Fargo	Outperform

View All

Inspire Medical Systems Inc Stock (INSP) Latest News

12:47 PM

Inspire Medical Systems' (INSP) Outperform Rating Reiterated at Royal Bank of Canada - MarketBeat

12:47 PM

12:46 PM

Smart Money Is Betting Big In INSP Options - Benzinga

12:46 PM

12:36 PM

Inspire Medical sales grow more than 30% in Street-beating Q3, full-year guidance raised - Mass Device

12:36 PM

11:35 AM

Inspire Medical Systems (NYSE:INSP) Receives "Hold" Rating from Stifel Nicolaus - MarketBeat

11:35 AM

09:52 AM

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts - Yahoo Finance

09:52 AM

09:00 AM

Inspire Medical Systems (NYSE:INSP) Releases Earnings Results, Beats Estimates By $0.54 EPS - MarketBeat

09:00 AM

08:38 AM

Inspire Medical Systems (NYSE:INSP) Price Target Raised to $252.00 - MarketBeat

08:38 AM

08:37 AM

Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2024 Earnings Call Transcript - MSN

08:37 AM

06:04 AM

Inspire Medical revenue jumps 33% to USD 203.2M in Q3 2024 - Medical Buyer

06:04 AM

05:34 AM

Inspire Medical revenue jumps 33% to USD 203.2M in Q3 of 2024 - Medical Buyer

05:34 AM

04:58 AM

Earnings call: Inspire Medical Systems reports strong Q3 growth, raises guidance - Investing.com

04:58 AM

02:09 AM